NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
Back to search
Official data from USPTO
VYRO BIOTHERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
10/31/2023
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
03/30/2022
Registration date
10/31/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
10/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
99
Owner location
Sao Paulo - SP, BR
Examiner
JOHNSON, DONALD
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an abstract microorganisms followed by the word VYRO in stylized font. Below the word Vyro appears the word Biotherapeutics in smaller font size.
Holders and representatives
Holders
VYRO BIOTHERAPEUTICS PESQUISA E DESENVOLVIMENTO DE PRODUTOS BIOTECNOLOGICOS LTDA
Representatives
Scott Houtteman HOUTTEMAN LAW LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of technology in the field of cancer killer virus technology or Oncolytics (Ovs)designed to target tumors in the central nervous system (CNS); Research and development in the field of technologiestechniques and methods in the treatment of diseases and in the field of health and medicine; Scientific study and research in the field(s) of biochemistry and biotechnology
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2023
PUBO
PUBLISHED FOR OPPOSITION
08/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2023
OTHE
CASE RETURNED TO EXAMINATION
07/10/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/10/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
07/06/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/06/2023
APET
ASSIGNED TO PETITION STAFF
07/05/2023
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
05/31/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/18/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2023
PUBO
PUBLISHED FOR OPPOSITION
02/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/16/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/14/2023
GNRT
NON-FINAL ACTION E-MAILED
01/14/2023
CNRT
NON-FINAL ACTION WRITTEN
01/14/2023
DOCK
ASSIGNED TO EXAMINER
01/14/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/05/2022
NWAP
NEW APPLICATION ENTERED
04/02/2022
Continuous trademark protection
Get notified about every new filing that threatens VYRO BIOTHERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.